Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late Botulinum Toxin Type A for Post-Stroke Upper Limb Spasticity
NCT02580838Phase 3Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Aug 2015
- Primary completion
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in spasticity, sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT02580838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580838.